Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants

Overview of attention for article published in Biologics: Targets & Therapy, September 2008

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 72 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 44 publications that cite this research output.

44

The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.

Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and Meta-Analysis

Article in Cureus (December 2023)

Genomic characterization of respiratory syncytial virus genotypes circulating in the paediatric population of Sydney, NSW, Australia

Article in Microbial Genomics (September 2023)

Diseño y estudio de fiabilidad del cuestionario de conocimientos, aptitudes y prácticas de progenitores sobre prevención y abordaje de bronquiolitis aguda en población pediátrica menor de dos años

Article in Anales del Sistema Sanitario de Navarra (April 2023)